DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Effect of a single dose of citalopram on amygdala response to emotional faces.

Author(s): Murphy SE, Norbury R, O'Sullivan U, Cowen PJ, Harmer CJ

Affiliation(s): Department of Psychiatry, Warneford Hospital, Oxford OX3 7JX. Susannah.Murphy@psych.ox.ac.uk

Publication date & source: 2009-06, Br J Psychiatry., 194(6):535-40.

Publication type: Randomized Controlled Trial; Research Support, Non-U.S. Gov't

BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) are typically thought to have a delay of several weeks in the onset of their clinical effects. However, recent reports suggest they may have a much earlier therapeutic onset. A reduction in amygdala responsivity has been implicated in the therapeutic action of SSRIs. AIMS: To investigate the effect of a single dose of an SSRI on the amygdala response to emotional faces. METHOD: Twenty-six healthy volunteers were randomised to receive a single oral dose of citalopram (20 mg) or placebo. Effects on the processing of facial expressions were assessed 3 h later using functional magnetic resonance imaging. RESULTS: Volunteers treated with citalopram displayed a significantly reduced amygdala response to fearful facial expressions compared with placebo. CONCLUSIONS: Such an immediate effect of an SSRI on amygdala responses to threat supports the idea that antidepressants have an earlier onset of therapeutically relevant effects than conventionally thought.

Page last updated: 2009-10-20

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017